Physician profile
Lea Kirkham
NPI 1912907239
$774.33
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $233 · 2021: $194 · 2022: $54.04.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $174.04 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $111.91 | 2019-2020 | |
| Neos Therapeutics, Lp | $96.38 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $66.89 | 2019-2022 | |
| Pfizer INC. | $51.40 | 2019-2021 | |
| Glaxosmithkline, LLC. | $49.30 | 2019-2021 | |
| Cranial Technologies, INC | $32.98 | 2019-2020 | |
| Alk-Abello, INC | $30.46 | 2021 | |
| Kaleo, INC. | $28.70 | 2019-2020 | |
| Sobi, INC | $25.08 | 2019 | |
| Tris Pharma INC | $23.18 | 2020-2021 | |
| Corium, LLC | $22.00 | 2021 | |
| Genentech USA, INC. | $20.26 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.48 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.97 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $13.30 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lea Kirkham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.